Suneet Mittal, MD

Trustee, Associate Chair of Cardiovascular Services, Valley Medical Group; Director of Electrophysiology, Medical Director of The Snyder Center for Comprehensive Atrial Fibrillation, The Valley Hospital; and Director of Cardiac Research, Valley Health System; Clinical Professor of Medicine, The Icahn School of Medicine, Mount Sinai Cardiac Services Cardiology Electrophysiology
VMG - Electrophysiology & Cardiology, New York
200 West 57th Street
Suite 610
New York, NY 10019
(212) 432-7837
Providing inpatient care
The Valley Hospital
223 N. Van Dien Avenue
Ridgewood, NJ 07450
(201) 689-7755
VMG - Electrophysiology, Paramus
970 Linwood Avenue
Suite 102
Paramus, NJ 07652
(201) 432-7837
VMG - Electrophysiology, Wayne Medical
1578 Route 23 North
Suite 103
Wayne, NJ 07470
(201) 432-7837
Board Certification
American Board of Internal Medicine, Subspecialty Board of Cardiovascular Disease, Clinical Cardiac Electrophysiology
Medical Education
Boston University, Boston University School of Medicine
Hospital of University of Pennsylvania
New York Hospital Cornell Medical Center, Hospital of University of Pennsylvania
What are some of the specific conditions you treat?

Outline a plan for diagnosis, evalulation, and management of patients at risk for or those who have already experienced arrhythmia; unexplained palpitations (sensation that the heartbeat is irregular or racing); unexplained stroke; unexplained syncope (fainting); cardiomyopathy (weakness of the heart muscle); specific arrhythmias such as skipped heartbeats, atrial fibrillation, atrial flutter, supraventricular tachycardia, atrial tachycardia, and ventricular tachycardia/fibrillation; cardiac arrest.

We are pleased to offer state-of-the-art techniques and procedures at The Valley Hospital to patients with suspected or known arrhythmias.

For patients who require implantation of a cardiac device: implantable loop recorders; pulmonary artery pressure sensors (CardioMEMS); left atrial appendage closure devices (watchman and lariat); permanent pacemakers, including leadless pacemakers, single and dual chamber pacemakers, His-bundle pacing, cardiac resynchronization therapy; implantable cardioverter-defibrillators (ICDs), including subcutaneous ICDs, single and dual chamber ICDs, cardiac resynchronization therapy; and a full suite of remote patient monitoring services available on a 24/7/365 basis.

For patients who require catheter ablation: three dimensional mapping, robotic catheter navigation, cryo and radiofrequency energy based ablation, focal impulse and rotor mapping (FIRM), hybrid ablation for patients with refractory atrial fibrillation, cardioversion, tilt table testing.

Describe some of your professional highlights.

My active research interests include the evaluation and management of patients with atrial fibrillation, the evaluation and management of patients with unexplained syncope, the role of implantable monitors in patients with known or suspected arrhythmias, and overcoming barriers to remote patient monitoring. I have been an invited speaker at major academic institutions, an invited faculty member (year in and year out) at the Annual Scientific Sessions of the American Heart Association, American College of Cardiology, and the Heart Rhythm Society, and an invited speaker in Europe and India. I serve as a co-ambassador to India for the Heart Rhythm Society. I am currently an associate editor for the Heart Rhythm Case Reports Journal. Finally, I am an invited reviewer to the leading journals in Cardiology and Electrophysiology, and I serve as an editorial board member of the Heart Rhythm Journal, the Journal of Interventional Cardiovascular Electrophysiology, and the Annals of Noninvasive Electrocardiology.

What would you like patients to know about your approach to care?

My approach to patient care can be summarized in the following seven words: "evidence-based, team directed, patient centered, healthcare." To accomplish this goal, I work hard to ensure that a full range of clinical and research opportunities are available to our patients so that I can deliver the right care at the right time. My goal is to treat the individual patient with a particular symptom and disease, not just the symptom or disease.

Top Doctors
Castle Connolly

High Patient Satisfaction
Press Ganey


Slotwiner D, Varma N, Akar JG, Annas G, Beardsall M, Fogel RI, Galizio NO, Glotzer TV, Leahy RA, Love CJ, Mclean RC, Mittal S, Morichelli L, Patton KK, Raitt MH, Ricci RP, Rickard J, Schoenfeld MH, Serwer GA, Shea J, Varosy P, Verma A, Yu CM. HRS expert c Heart Rhythm 12: e69-e100. 2015.

Varma N, Piccini JP, Snell J, Fischer A, Dalal N, Mittal S. The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. J Am Coll Cardiol 65:2601-2610. 2015.

Ghosh S, Stadler RW, Mittal S. Automated detection of effective left ventricular pacing: Going beyond percentage pacing counters. Europace doi:10.1093/europace/euv062. 2015.

Mittal S, Aktas M, Moss AJ, McNitt S, Kutyifa V, Steinberg JS, Zareba W. The impact of non-sustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT (Multicenter Automatic Implantation Trial-cardiac Resynchronization Therapy. J Cardiovasc Electrophysiol doi: 10.1111/jce.12456. 2014.

Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, Preminger M, Sichrovsky T, Steinberg JS. Cardiac implantable electronic device infections: Incidence, risk factors, and the effect of the AigisRX antibacterial envelope. Heart Rhythm 11: 595-601. 2014.

Clinical Trials

Evaluation of ACUITY™ X4 Quadripolar Coronary Venous Leads and RELIANCE™ 4-FRONT Defibrillation Leads (NAVIGATE X4)

(PRAETORIAN) A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy 

I am the United States national PI for the PRAETORIAN trial. The aim of this trial is to assess the advantages and disadvantages of the subcutaneous implantable cardioverter defibrillator (ICD) compared to the transvenous ICD.

World-wide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT)

I am on the Steering Committee of the WRAP-IT trial. The aim of this trial is to evaluate the ability of the TYRX antimicrobial envelope to reduce major cardiac implantable electronic device (CIED) infections through 12-months post-procedure following CIE

Boston Scientific
Rhythm Management Medical Advisory Board (MAB)

Biosense Webster, Boston Scientific, Medtronic, Philips Healthcare, SentreHeart, Sorin, St. Jude Medical

"Dr. Mittal is a highly proficient, very intelligent physician. His friendliness is outstanding. I am always relaxed and never apprehensive when I visit him."
"The time and effort he gives to answering questions, concerns and explanations of upcoming procedure is admirable. I feel very fortunate to have Dr. Mittal as my doctor."
"Thank you Dr. Mittal for your extraordinary care to my heart. You are the best. You are simply extraordinary."
"Dr. Mittal is very caring and shows concern and professionalism. I have every confidence in his medical decision-making."